Callidus Software Announces Strategic Agreement With IMS Health

Published 17th January 2008

Alliance Delivers Leading Sales Performance Management Solutions to Pharmaceutical and Healthcare Industries...

London, UK, January 17, 2008 — Callidus Software Inc. (NASDAQ: CALD), the leader in Sales Performance Management (SPM), today announced it has entered an exclusive resale agreement with IMS Health, the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. Callidus On-Demand will be deployed as IMS’s software platform for IMS’s new global sales force incentive compensation offering, IMS Precision Compensation™, an offering designed to leverage IMS’s unmatched market insights with Callidus’ industry-leading SPM and incentive compensation software products, services and expertise.

“With complex and fluid selling models, it is clear that effective sales performance and incentive compensation management are critical in the pharmaceutical industry,” said Leslie Stretch, president and CEO at Callidus Software. “Callidus has already demonstrated strong momentum, with three of the five largest US pharmaceutical manufacturers as customers. We are excited about this important alliance and will work closely with IMS and its global sales force and customer base to dramatically extend our reach into this industry.”

“After thorough evaluation, we found Callidus On-Demand delivered the best underlying technology to support the Precision Compensation offering,” said Sati Sian, global general manager, Sales Force Effectiveness at IMS. “In sales force incentive compensation, flexibility is paramount. The Callidus software solution enables IMS to deploy a client offering that helps pharmaceutical companies lower their total costs, implement more effective sales plan design and cut time to market for incentive compensation payouts – important fundamentals that drive our client’s ability to achieve intended sales results.”